Conditions: Symptomatic Focal Vitreomacular Adhesion
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 45
Healthy volunteers: no

Brief summary:
Evaluate the safety and efficacy of ophthalmic intravitreal injection of ALG-1001 in human subjects with symptomatic focal vitreomacular adhesion

Detailed description:

Arms:
arm 1: 2.0mg of ALG-1001 arm 2: Balanced Salt Solution

Interventions: intervention 1: 2.0mg of ALG-1001 intervention 2: Balanced Salt Solution
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: